@HealthReadiness
info@healthsystemreadiness.com
  • All
  • Events
  • News
  • Opinion
  • Radioligand Therapy
    • Opinion
    Patient advocacy in action: discussion with Mark McDonnell

    Patient advocacy in action: discussion with Mark McDonnell

    Mark McDonnell is Chairperson of the NET Patient Network in Ireland and President of the International Neuroendocrine Cancer Alliance (INCA).
    Read More
    Opinion
    Why we need readiness for advanced diagnostics

    Why we need readiness for advanced diagnostics

    New diagnostic technologies will be fundamental in the shift towards personalised healthcare. Health systems must be ready to integrate these technologies into routine care.
    Read More
    Opinion
    Why we need system readiness to promote eye health

    Why we need system readiness to promote eye health

    System readiness means ensuring that health systems keep pace with societal changes. A perfect illustration of this is the need to address the growing prevalence of vision loss.
    Read More
    Opinion
    Why is readiness important in cancer care?

    Why is readiness important in cancer care?

    As more and more people are living with cancer every year, and health systems face additional burdens, readiness for innovations in cancer care is becoming increasingly important.
    Read More
    Opinion
    Glossary: what does readiness really mean?

    Glossary: what does readiness really mean?

    The terms readiness, preparedness, resilience, strengthening and sustainability often appear in similar health contexts, but they mean different things.
    Read More
    Opinion
    Why we need to think about readiness for ALS

    Why we need to think about readiness for ALS

    ALS has a profound impact on people’s lives; new innovations are on the horizon, but it is important to consider how ready our health systems are to integrate new therapies.
    Read More
    Opinion
    Why we need readiness in NASH

    Why we need readiness in NASH

    Health systems need to be ready to respond to evolving evidence to ensure they can always deliver efficient and equitable care. The approval of a therapy would transform care for n
    Read More
    Opinion
    When is the right time to think about health system readiness?

    When is the right time to think about health system readiness?

    Decision-makers must plan for the sustainable and timely integration of new technologies and processes into care.
    Read More
    Opinion
    How consistent terminology can aid integration of radioligand therapy

    How consistent terminology can aid integration of radioligand therapy

    Inconsistent use of terminology presents challenges to building awareness of radioligand therapy and appropriately integrating it into care.
    Read More
    Opinion
    The impact of COVID-19 highlights the need for innovative therapies in cancer care

    The impact of COVID-19 highlights the need for innovative therapies in cancer care

    COVID-19 has caused widespread disruption to cancer care. New approaches could provide more options for people with advanced, complex or metastatic cancers.
    Read More
    Opinion
    World Theranostics Day 2022: what are theranostics and how can we use them?

    World Theranostics Day 2022: what are theranostics and how can we use them?

    On World Theranostics Day 2022, HPP explores the ongoing innovation and advancement in the field of theranostics.
    Read More
    Opinion
    We need continued research to ensure wider access to innovative therapies as soon as they are approved

    We need continued research to ensure wider access to innovative therapies as soon as they are approved

    In this guest blog, Dr Erik Briers emphasises the need for continued research and planning to make radioligand therapy a more viable treatment option.
    Read More